Why Is Dentsply Sirona Acquiring MIS Implants?




Dentsply Sirona (XRAY) is a leading dental equipment and technologies manufacturer. The company was formed through the merger of Dentsply and Sirona in February 2016. It’s present in more than 120 countries. It registered revenues of ~$2.7 billion in 2015. To gain diversified exposure to Dentsply Sirona, investors can consider the Guggenheim S&P 500 Equal Weight ETF (RSP). RSP holds ~0.20% of its total holdings in Dentsply Sirona.

Dentsply Sirona’s major competitors are Align Technologies (ALGN), Zimmer Biomet Holdings (ZBH), and Integra Lifesciences Holdings (IART). To learn more about the company, read An Investor’s Guide to Dental Manufacturer Dentsply Sirona.

Article continues below advertisement

MIS company details

MIS is mainly a dental implants and prosthetics manufacturer. It also provides grafting materials and guided surgery services. The company offers a broad range of implant therapy products used during all treatment stages. The company sells it products in ~65 countries.

The V3 implant system was the company’s most recent launch. The product offers a more efficient implant with reduced pressure in the coronal area.

Acquisition rationale

Dentsply Sirona is acquiring MIS due to its established brand and broad portfolio of implants and related products. The company aims to address different segments including premium as well as the value customer segment through MIS’s broad product portfolio. It expects the deal to result in higher growth opportunities. It plans to serve its customers better and provide more value through a broader product portfolio. Also, MIS’s product portfolio complements Dentsply Sirona’s existing product lines.


More From Market Realist